You have 9 free searches left this month | for more free features.

iNO

Showing 26 - 50 of 255

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia, ph+ Acute Lymphoblastic Leukemia Trial in Chicago (Inotuzumab ozogamicin,

Recruiting
  • Lymphoblastic Leukemia
  • +2 more
  • Inotuzumab ozogamicin
  • +7 more
  • Chicago, Illinois
    University of Chicago Medical Center
May 16, 2022

Dyspnea Trial (Nitric Oxide, Placebo)

Not yet recruiting
  • Dyspnea
  • Nitric Oxide
  • Placebo
  • (no location specified)
Dec 5, 2022

ACUTE LYMPHOBLASTIC LEUKEMIA Trial (Inotuzumab ozogamicin, ALLR3)

Not yet recruiting
  • ACUTE LYMPHOBLASTIC LEUKEMIA
  • (no location specified)
Feb 17, 2023

Prematurity, Bronchopulmonary Dysplasia, Intraventricular Hemorrhage Trial in Chicago (inhaled nitric oxide, oxygen)

Active, not recruiting
  • Prematurity
  • +3 more
  • Chicago, Illinois
    The University of Chicago
Nov 7, 2022

Coronavirus Infection, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), COVID-19 Disease Trial in Colombia, Mexico,

Active, not recruiting
  • Coronavirus Infection
  • +2 more
  • Chandler, Arizona
  • +26 more
Jun 9, 2022

HIV-1-infection Trial in Los Angeles, San Francisco (PENNVAX-GP, INO-6145, INO-9012)

Completed
  • HIV-1-infection
  • PENNVAX-GP
  • +3 more
  • Los Angeles, California
  • +1 more
Apr 4, 2022

Heart Transplant Surgery, Lung Transplant Surgery Trial in Durham (iNO, iEPO)

Completed
  • Heart Transplant Surgery
  • Lung Transplant Surgery
  • Durham, North Carolina
    Duke Health
Feb 14, 2022

Hypoxia Trial in Edmonton (Nitric Oxide, Placebo)

Completed
  • Hypoxia
  • Nitric Oxide
  • Placebo
  • Edmonton, Alberta, Canada
    Clinical Physiology Laboratory
Jul 12, 2022

Head Neck Cancer, Human Papilloma Virus Trial in United States (MEDI0457, CELLECTRA®5P device, Durvalumab)

Completed
  • Head and Neck Cancer
  • Human Papilloma Virus
  • San Francisco, California
  • +13 more
Aug 3, 2022

Pulmonary Hypertension, Bronchopulmonary Dysplasia Trial in Orlando (inhaled nitric oxide, Placebo)

Recruiting
  • Pulmonary Hypertension
  • Bronchopulmonary Dysplasia
  • inhaled nitric oxide
  • Placebo
  • Orlando, Florida
    AdventHealth
Apr 15, 2022

Pulmonary Fibrosis, Pulmonary Hypertension Trial (INOpulse)

Available
  • Pulmonary Fibrosis
  • Pulmonary Hypertension
  • INOpulse
  • (no location specified)
Apr 26, 2022

Idiopathic Pulmonary Fibrosis Trial in Kingston (Nitric Oxide, Medical air)

Recruiting
  • Idiopathic Pulmonary Fibrosis
  • Nitric Oxide
  • Medical air
  • Kingston, Ontario, Canada
    Respiratory Investigation Unit, Kingston General Hospital
Apr 21, 2022

Triple Negative Breast Cancer Trial (Seviteronel-D (Seivteronel in combination with dexamethasone), Docetaxel)

Not yet recruiting
  • Triple Negative Breast Cancer
  • Seviteronel-D (Seivteronel in combination with dexamethasone)
  • Docetaxel
  • (no location specified)
Sep 21, 2021

Cervical Cancer Trial in Chicago, Ann Arbor, New York (INO-3112, CELLECTRA™-5P)

Completed
  • Cervical Cancer
  • INO-3112
  • CELLECTRA™-5P
  • Chicago, Illinois
  • +2 more
Feb 1, 2021

InO - A Retrospective Study of UK Patients With Leukaemia

Completed
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma
  • Inotuzumab Ozogamicin
  • Bristol, United Kingdom
  • +3 more
Jan 27, 2022

Lassa Fever Trial in Kansas City (INO-4500, Placebo, CELLECTRA® 2000)

Completed
  • Lassa Fever
  • Kansas City, Missouri
    The Center for Pharmaceutical Research
Nov 20, 2020

Head and Neck Squamous Cell Cancer Trial in Philadelphia (INO-3112, CELLECTRA™-5P)

Completed
  • Head and Neck Squamous Cell Cancer
  • INO-3112
  • CELLECTRA™-5P
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Jan 4, 2021

COPD Trial in Kingston (Nitric Oxide, Placebo)

Recruiting
  • Chronic Obstructive Pulmonary Disease
  • Nitric Oxide
  • Placebo
  • Kingston, Ontario, Canada
    Respiratory Investigation Unit, Kingston General Hospital
Sep 24, 2021

Pulmonary Fibrosis, Pulmonary Hypertension Trial in United States (INOpulse®, Placebo, Long Term Follow Up)

Active, not recruiting
  • Pulmonary Fibrosis
  • Pulmonary Hypertension
  • INOpulse®
  • +2 more
  • Phoenix, Arizona
  • +22 more
Feb 17, 2023

Metastatic Castration-resistant Prostate Cancer Trial in United States (drug, radiation, device)

Completed
  • Metastatic Castration-resistant Prostate Cancer
  • NKTR-214 (Cohort A)
  • +6 more
  • Los Angeles, California
  • +5 more
Nov 10, 2022

Respiratory Distress Syndrome in Premature Infants, Very Low Birth Weight Baby Trial in Oklahoma City (iNO, Nitrogen)

Completed
  • Respiratory Distress Syndrome in Premature Infants
  • Very Low Birth Weight Baby
  • iNO
  • Nitrogen
  • Oklahoma City, Oklahoma
  • +1 more
Aug 7, 2020

Non-Tuberculous Mycobacterial Pneumonia, Cystic Fibrosis, Mycobacterial Pneumonia Trial in Greenslopes (LungFit)

Recruiting
  • Non-Tuberculous Mycobacterial Pneumonia
  • +4 more
  • LungFit
  • Greenslopes, Queensland, Australia
    Gallipoli Medical Research Foundation
Dec 24, 2020

COPD, Pulmonary Hypertension Trial (Nitric Oxide Generation and Delivery System)

Not yet recruiting
  • Chronic Obstructive Pulmonary Disease
  • Pulmonary Hypertension
  • Nitric Oxide Generation and Delivery System
  • (no location specified)
Mar 14, 2023

Inhaled Nitric Oxide on Pulmonary Ventilation/Perfusion Ratio

Recruiting
  • Critical Illness
    • Wuhan, Hubei, China
      Hongling Zhang
    May 15, 2023

    COPD Trial (Nitric Oxide Generation and Delivery System)

    Not yet recruiting
    • Chronic Obstructive Pulmonary Disease
    • Nitric Oxide Generation and Delivery System
    • (no location specified)
    Jun 1, 2023